As Western New York residents continue to navigate the evolving landscape of digital healthcare, Amazon is making a significant move that could alter how local
Federal regulators have granted expedited approval to Eli Lilly’s latest pharmaceutical breakthrough, Foundayo (orforglipron). This daily oral medication is designed to treat obesity and weight-related